The impact of COVID19 pandemic-related activity restriction on the outcomes of chronic obstructive lung disease

The impact of COVID19 pandemic-related activity restriction on the outcomes of chronic obstructive lung disease - ICARD study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042106

Enrollment

150

Registered

2020-10-15

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic obstructive lung disease(COPD)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: COPD: Patients who meet three criteria: (1-1) cases diagnosed as COPD on registration (2) above 40 years-old (3) written informed consent Non-COPD: Patients who meet three criteria: (1-2) never-smokers with FEV1/FVC >70% (2) above 40 years-old (3) written informed consent

Exclusion criteria

Exclusion criteria: (1) cases who disagree with evaluation of COPD status (2) cases who investigators could not evaluate the incidence of COPD-related AE by medical record (3) cases carrying malignant tumors (4) cases with asthma

Design outcomes

Primary

Measure	Time frame
Physical activity evaluated by IPAQ during COVID19 pandemic period	—

Secondary

Measure	Time frame
1. Sedentary time during COVID19 pandemic period 2. Prevalence of COVID19 in this study population 3. The numbers of COPD-related acute exacerbation (AE) after COVID19 pandemic 4. The chance of spirometric valuables after COVID19 pandemic 5. Estimation of anxiety and depression evaluated by HADS on enroll 6. Identification of factors related to COPD-AE	—

Countries

Japan

Contacts

Public ContactAkira Ando

Nagoya University Graduate School of Medicine Department of Respiratory Medicine

ICARD.kokyuki@outlook.jp0527442167

Outcome results